Kidney Reagents for Luminex 3D Analyzer
ID: JA240200Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/5e87736101a841e6a6431f40835cd337/view
Timeline
    Description

    The Defense Health Agency (DHA) intends to award a sole source contract for Kidney Reagents for the Luminex 3D Analyzer, specifically for the Kidney Transplant Clinic at The Walter Reed National Military Medical Center in Bethesda, Maryland. The procurement aims to secure molecular and serological reagents from One Lambda Inc. that are essential for transplant testing, ensuring compatibility and reducing the risk of organ rejection between donors and recipients. These reagents are critical as they have been validated by the American Society of Histocompatibility and Immunogenetics (ASHI) and are necessary for maintaining the accreditation of the Immunology Lab. Interested parties may express their interest and provide a capability statement to Barbara Sonnier at barbara.n.sonnier.civ@health.mil by September 24, 2024, at 10:00 PM EST.

    Point(s) of Contact
    Barbara Sonnier
    barbara.n.sonnier.civ@health.mil
    Carlos Sikaffy
    carlos.a.sikaffy.civ@health.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Kidney Reagents for Luminex 3D Analyzer
    Currently viewing
    Special Notice
    Similar Opportunities
    Medical Reagents for USNH Okinawa
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support Pacific is conducting a sources sought announcement to identify local sources capable of providing medical laboratory reagents for the United States Naval Hospital (USNH) in Okinawa, Japan. The procurement involves the delivery of CLASS VIII medical laboratory reagents, including Ortho reagents and consumables compatible with VITROS 5600 Analyzers, along with necessary training and maintenance services for the equipment. This opportunity is critical for ensuring the availability of essential medical supplies and maintaining compliance with healthcare standards in a military setting. Interested parties must submit their qualifications and relevant information by September 30, 2024, to the primary contacts, Bradley Ah Nee and Arlene Renner, via email at bradley.ahnee@dla.mil and arlene.renner@dla.mil, respectively. The estimated contract value is under $5.4 million, covering a base period of 12 months with two optional periods.
    Notice of Intent - Ortho Clinical Reagents and Supplies
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a fixed-price contract for Ortho Clinical reagents and supplies, specifically for the Department of Transfusion Medicine at the NIH Clinical Center in Bethesda, Maryland. This procurement aims to secure essential analyzer supplies and reagents that are critical for ensuring the safety and effectiveness of blood products used in transfusion therapy, which must meet specific compatibility requirements for patient treatment. The selected supplier, Ortho-Clinical Diagnostics, Inc., is the sole source for these unique reagents, which have undergone extensive validation studies and are necessary for compatibility testing of both patients and blood donors. Interested parties capable of providing similar products may submit a capability statement by September 22, 2024, to Sheri Eiri at sheri.eiri@nih.gov, as the contract is contingent upon the availability of FY2025 funding.
    CHEMISTRY AND IMMUNOASSAY TESTING PROGRAM
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is planning to issue a sole source award contract to Roche Diagnostics Corporation for the Chemistry and Immunoassay Testing Program. This program is intended to sustain the use of three Chemistry and Immunochemistry Systems under a Cost Per Reportable Result (CPRR) agreement or Cost Per Reagent Pack. The program includes equipment, reagents, tools, materials, training, and a water purification system, Uninterruptible Power Supply (UPS), and services necessary to meet the Chemistry and Immunochemistry testing and analysis requirements for Walter Reed National Military Medical Center (WRNMMC) laboratories. The anticipated period of performance is five years.
    6550--ALBAcyte Red Blood Cell Reagents-Notice of Intent to Sole Source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 10, intends to negotiate a sole source contract for ALBAcyte Red Blood Cell Reagents with Alba Bioscience Inc. This procurement is essential for the Blood Bank Department at the Richard L. Roudebush VA Medical Center, as it involves specialized reagents necessary for blood typing and compatibility testing critical for patient transfusions. The urgency of this acquisition is underscored by the unique quality of the reagents from Alba Bioscience, which eliminates the need for repeated validations from other sources. Responses to this notice must be submitted by 2:00 pm EST on September 23, 2024, to Contract Specialist Lonnelle Jones at lonnelle.jones@va.gov, as no solicitation package will be provided.
    CHEMISTRY AND IMMUNODIAGNOSTICS REAGENTS FOR Bassett Army Community Hospital
    Active
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office - Pacific, intends to modify an existing contract to procure additional Chemistry and Immunodiagnostics Reagents for the Bassett Army Community Hospital in Alaska. This modification aims to increase supply quantities under existing Contract Line Item Numbers (CLINs) for the upcoming Option Period III in Fiscal Year 2024. These reagents are critical for diagnostic testing and patient care within military medical facilities. Interested vendors can reach out to Garrett Wada at garrett.k.wada.civ@health.mil or call 808-433-9505, or contact Riley Yogi at riley.r.yogi.civ@health.mil or 808-433-9513 for further details.
    Notice of Intent to Sole Source - Ortho-Clinical Blood Cards Reagent -
    Active
    Dept Of Defense
    The Department of Defense, specifically the Army Health Contracting Activity, intends to award a sole source contract to Ortho-Clinical Inc. for the procurement of red blood cell reagent cards necessary for the Government-owned Ortho Vision ID-MTS Workstation analyzer at Irwin Army Community Hospital in Fort Riley, Kansas. This procurement is classified as sole source due to the unique proprietary nature of the required supplies, which are exclusively produced by Ortho Clinical Diagnostics and have a short expiration period, necessitating timely acquisition. The contract is expected to be awarded on or about September 17, 2024, with funding anticipated from FY 2025, and interested parties may direct inquiries to Perry J. Cannon at perry.j.cannon.civ@health.mil.
    Intent to sole source Biomerieux Vitek2 Preventative maintenance and Consumables
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Biomerieux Japan Ltd. for the supply of specific VITEK 2 test cards and annual preventive maintenance services for the U.S. Naval Hospital Yokosuka and Branch Health Clinic Iwakuni in Japan. The procurement includes a delivery schedule spanning fiscal years 2025 to 2027, detailing quantities for three types of test cards essential for laboratory analyses, along with maintenance for two Vitek 2 Compact Analyzers. This contract is critical for ensuring effective healthcare delivery to U.S. Forces Japan personnel, and interested vendors may submit technical capability statements by 07:00 a.m. Pacific Time on 23 September 2024, to Raphael Badagbor at raphael.k.badagbor.civ@health.mil, as no competitive proposals will be solicited.
    6550--VISN Multiplex PCR Testing Reagents/Consumables Intent to sole source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Great Lakes Acquisition Center, intends to negotiate a sole source contract with BioMerieux, Inc. for the provision of proprietary reagents and consumables necessary for PCR testing on government-owned devices across facilities in Wisconsin, Illinois, and Michigan. This procurement is essential to ensure that the VA can maintain high-quality healthcare services, as only BioMerieux is deemed capable of meeting the specialized requirements for these supplies. The contract will be established as a Blanket Purchase Agreement (BPA) under an existing contract, categorized as firm fixed price, and is being conducted in accordance with FAR 8.405-6. Interested firms must submit their qualifications and relevant customer references to the Contracting Officer, Teresa Beers, at teresa.beers@va.gov within seven calendar days from the publication date of this notice, as no competitive proposals will be solicited.
    Medical Sysmex Reagents and Microbiological Media Plates
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support Pacific is conducting market research to identify local sources for the procurement and delivery of medical laboratory reagents and microbiological media plates in support of the United States Naval Hospital (USNH) located in Okinawa, Japan. This sources sought announcement aims to gather information on potential suppliers capable of fulfilling a requirement for Class VIII medical supplies, which are critical for laboratory diagnostics and healthcare operations. The anticipated contract will be a Firm-Fixed Price Indefinite Delivery, Indefinite Quantity type, with a base period of 12 months and one option period, estimated under $250,000, inclusive of shipping and delivery. Interested parties must submit their responses by 12:00 pm JST on October 13, 2024, to the designated contacts, Mamiko Jackson and Arlene Renner, via email.
    Notice of Intent to Sole-Source - Hematology Analyzer Services
    Active
    Dept Of Defense
    The Department of Defense, specifically the 341st Contracting Squadron at Malmstrom Air Force Base in Montana, intends to award a sole-source contract to Sysmex America, Inc. for routine preventative maintenance services and reagents for the Sysmex Hematology Analyzer Unit. This procurement is critical as the analyzer requires specific reagents that are exclusively provided by Sysmex America, making them the only viable source for fulfilling this requirement. Interested parties may submit a capability statement or proposal demonstrating why competitive bidding would be advantageous, with submissions due by 14 October 2024 at 2:00 PM MST. For further inquiries, contact SSgt Kevin Luccitti at kevin.luccitti@us.af.mil or SSgt Joshua Crist at joshua.crist.1@us.af.mil.